RxDoctor Payments Data

Deepak Lachhwani, MD

Neurology with Special Qualifications in Child Neurology · Cleveland, OHNPI 1073553541

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Biocodex, Inc. accounts for 82.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $3,540 and has fallen 96.5% since, to $125 in 2025.

$4,165in general payments, 2019–2025

Across 11 payments — averaging $378.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biocodex, Inc.$3K
  • UCB, Inc.$368
  • SK Life Science, Inc.$181
  • E.r. Squibb & Sons, L.L.C.$119
  • Mallinckrodt Hospital Products Inc.$82
$101,738in research payments, 2019–2025

Across 24 payments — averaging $4239.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • SK Life Science, Inc.$102K

What the payments were for

  • Speaking & faculty fees$2,46459%
  • Travel & lodging$83520%
  • Food & beverage$86621%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,165 in reported general payments places this provider in the 70th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$4,752
Medicare patients
67
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)13$66,890

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →